期刊文献+

滋阴明目丸治疗湿性老年性黄斑变性的临床观察 被引量:21

Clinical observation of the effect of Ziyin Mingmu Pills(滋阴明目丸) on patients with age-related macular degeneration
下载PDF
导出
摘要 目的观察滋阴明目丸对湿性老年性黄斑变性的临床疗效。方法将确诊为湿性AMD患者64例(73只眼)按就诊先后次序分为滋阴明目丸组和明目地黄丸组。分别给予相应药物治疗,30天为1疗程,连续3个疗程。观察治疗前后远视力、眼底出血、血液流变、血脂及中医症状积分的情况。结果两组药物均有治疗湿性老年性黄斑变性的作用,滋阴明目丸组疗效优于明目地黄丸组(P<0.05)。结论滋阴明目丸对湿性老年性黄斑变性有一定的治疗作用。 OBJECTIVE To observe the clinical effect of Ziyin Mingmu Pills(滋阴明目丸)on the patients with age - related macular degeneration(AMD).METHODS All the 64 cases of AMD were randomly divided into two groups: Ziyin Mingmu Pills group( n = 32) and Mingmu Dihuang Pills( 明目地黄丸) group( n = 32). Gave correspond drug treat- ment respectively for 3 courses, 30 days as a course of treatment. The following clinical indexes of curative effect were observed before and after treatment: vision, fundus hemorrhage, blood fats, hemorheoloy and the multiple scores of manifestation of TCM. RESULTS Both groups had the function for treating AMD. Compared the clinical effect, Ziyin Mingmu Pills group was superior to Mingmu Dihuang Pills group( P 〈 0.05). CONCLUSIONS Ziyin Mingmu Pills had a certain effect on AMD.
机构地区 湖南中医学院
出处 《中国中医眼科杂志》 2007年第6期311-314,共4页 China Journal of Chinese Ophthalmology
关键词 滋阴明目丸 明目地黄丸 湿性老年性黄斑变性 Ziyin Mingmu Pills (滋阴明目丸 ) Mingmu Dihuang Pills ( 明目地黄丸) wet form age - related macular degeneration, AMD
  • 相关文献

参考文献8

二级参考文献21

  • 1彭清华,李传课.视网膜色素变性虚中夹瘀的机理研究小结[J].中国医药学报,1993,8(6):7-10. 被引量:40
  • 2中华医学会眼科学会眼底病学组.老年性黄斑变性临床诊断标准[J].眼底病,1987,3:3-3.
  • 3刘家琦 李风鸣.实用眼科学:第2版[M].北京:人民卫生出版社,1997.509-511.
  • 4Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy
  • 5Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for
  • 6Bressler SB, Pieramici DJ, Koester JM, et al. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to
  • 7Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analy
  • 8Treatment of Age-related macular degeneration with Photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial
  • 9Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in agerelated macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neov
  • 10Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol, 1998,43:134-146.

共引文献82

同被引文献265

引证文献21

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部